Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP1 | P07148 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 2/20 | 0.39 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.37 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
| ▸ | ERN1 | O75460 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.34 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22065174 | 0.94 | FABP1 (0.45) | FABP1PIM1SLC40A1GLO1CYP17A1 | |
| SCHEMBL22064807 | 0.92 | FABP1 (0.41) | FABP1PIM1PDPK1SLC40A1GLO1 | |
| SCHEMBL22065172 | 0.92 | FABP1 (0.40) | FABP1PIM1PDPK1SLC40A1GLO1 | |
| SCHEMBL22065434 | 0.90 | CYP11B2 (0.43) | FABP1PIM1PDPK1SLC40A1GLO1 | |
| SCHEMBL22065435 | 0.89 | CYP11B2 (0.39) | FABP1PIM1PDPK1SLC40A1GLO1 | |
| SCHEMBL22064715 | 0.87 | FABP1 (0.45) | FABP1PIM1PDPK1SLC40A1GLO1 | |
| SCHEMBL22065420 | 0.87 | FABP1 (0.45) | FABP1PIM1PDPK1SLC40A1GLO1 | |
| SCHEMBL22065162 | 0.86 | FABP1 (0.46) | FABP1PIM1PDPK1SLC40A1GLO1 | |
| SCHEMBL22065455 | 0.86 | SLC40A1 (0.40) | FABP1PIM1PDPK1SLC40A1GLO1 | |
| SCHEMBL22064699 | 0.85 | FABP1 (0.45) | FABP1PIM1SLC40A1GLO1CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200181096-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181096-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, AHR | FABP1 4043/4885PIM1 2372/4885PDPK1 3671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.